Stocktoria
Imunon, Inc. IMNN
Nasdaq · stock · Pharmaceutical Preparations · website · IPO 1993-10-27
Imunon, Inc. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else from the latest financial reports.
Profitability & efficiency
Margins and returns computed from annual filings. Falling shares outstanding = buybacks; rising = dilution. Net debt = debt − cash (negative = net cash).
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating margin | — | — | — | -4984.3% | -4201.4% | -3697.3% | -4113.1% | -4213.0% | -3693.7% | — |
| Net margin | — | — | — | -7179.6% | -4153.9% | -4296.7% | -3370.3% | -2376.7% | -4080.4% | — |
| FCF margin | — | — | — | -4672.9% | -3307.0% | -3127.6% | -4121.6% | -1436.0% | -3336.1% | — |
| Return on assets | -118.0% | -191.6% | -89.0% | -81.6% | -28.0% | -57.2% | -44.0% | -25.4% | -42.9% | -71.5% |
| Return on equity | -205.3% | -438.7% | -145.8% | -122.4% | -37.2% | -115.4% | -115.7% | -57.0% | -76.4% | -327.9% |
| Debt / equity | — | — | — | 0.20× | — | 0.27× | 0.67× | 0.45× | — | — |
| Current ratio | 2.32 | 1.67 | 2.47 | 3.66 | 7.67 | 2.79 | 2.06 | 4.61 | 3.92 | 0.54 |
Computed from company filings · US · as of 2025-12-31. Facts plus Stocktoria's own computed scores — not investment advice.